Rasmus Mortensen, Cecilia S. Lindestam Arlehamn, Rhea N. Coler, Michael Y. Gerner, Delia Goletti, Deborah A. Lewinsohn, Robert L. Modlin, Munyaradzi Musvosvi, Jyothi Rengarajan, Kevin B. Urdahl, Gerhard Walzl, Samuel M. Behar, Daniel L. Barber
Tuberculosis (TB) remains a leading infectious cause of morbidity and mortality, and the development of a new, highly effective vaccine would have a tremendous beneficial impact on global health. Although conventional memory CD4 and CD8 T cells will likely be key mediators of long-lived, vaccine-elicited protection, a potent T cell-inducing vaccine against TB has been elusive. Protection by Mycobacterium tuberculosis (Mtb)-specific T cells is mediated primarily through their communication with Mtb-infected macrophages. Here, we discuss emerging evidence of multiple structural and immunoregulatory factors that limit effective T cell-macrophage interactions in TB granulomas, posing a unique challenge to vaccine-induced protection. Developing new TB vaccination strategies will require a better understanding of the crosstalk between T cells and infected pulmonary macrophages and strategies to enhance these interactions.